Astragenol

Astragenol is an intermediate used for Astragenol derivative synthesis. Astragenol derivatives are promising anti-inflammatory agents for prostate cancer research[1].

Product Specifications

CAS Number

[86541-79-9]

UNSPSC

12352005

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/astragenol.html

Purity

98.0

Solubility

Ethanol : 50 mg/mL (ultrasonic)

Smiles

C[C@]([C@]([C@](O[C@@H]1C(C)(O)C)(CC1)C)([H])[C@H]2O)(CC=C([C@]([C@]3([H])C4(C)C)(CC[C@@H]4O)C)[C@@]5([H])C[C@@H]3O)[C@]5(C2)C

Molecular Formula

C30H50O5

Molecular Weight

490.72

References & Citations

[1]Bilge Debeleç-Bütüner, et al. Cycloartane-type sapogenol derivatives inhibit NF-κB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. Steroids. 2018 Jul;135:9-20.